1-4 of 4
K. Govind Babu
Close
Sort by
Journal Articles

Induction Related Mortality in Acute Myeloid Leukemia: Multivariate Model of Predictive Score from the Indian Acute Leukemia Research Database (INwARD) of the Hematology Cancer Consortium (HCC)

Smita Kayal, MD DM, Manju Sengar, MD DM, Hasmukh Jain, MD DM, Avinash Bonda, MD DM, Biju George, MDDM, Uday Prakash Kulkarni, MD DM, Poonkuzhali Balasubramanian, PhD, Dinesh Bhurani, MD DM, FRCPA, Rayaz Ahmed, MDDM, Dubashi Biswajit, MD DNB, DM, Jayachandran PK, MD MRCP, DM, Ankit Batra, MD, Suman Kumar, MD DM, Kundan Mishra, MD DM, Jina Bhattacharyya, MD DM, Chepsy C Philip, MD, Maitreyee Bhattacharyya, MD DM, Lokanatha Dasappa, MD, K Govind Babu, MD DM, Smitha Carol Saldanha, DM, MBBS, MD, Atul Sharma, MD DM, Jeyaseelan Lakshmanan, PhD, Jothilakshmi Durairaj, M.Sc., Vishnu Vardhan Rudravaram, PhD, Vikram Mathews, MD DM, Rajan Kapoor, MD DM
Journal: Blood
Blood (2019) 134 (Supplement_1): 2615.
https://doi.org/10.1182/blood-2019-127623
Published: 2019
Journal Articles

Long-Term Evaluation of Efficacy and Safety of Ofatumumab Added to Fludarabine & Cyclophosphamide in Subjects with Relapsed Chronic Lymphocytic Leukemia: Final Analysis of Complement 2 Trial

Sebastian Grosicki, MD PhD, Ewa Lech-Maranda, MD PhD, K Govind Babu, MD DM, Justyna Rybka, MD PhD, Elena Litvinskaya, PhD, Javier Loscertales, MD, Irina Kryachok, Prof., PhD, Janusz Kłoczko, Prof., PhD, Grygoriy Rekhtman, MD, Wojciech Homenda, MD PhD, Jerzy Blonski, MD PhD, Tommaso Stefanelli, Ghislaine Vincent, Hiya Banerjee, Tadeusz Robak, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3151.
https://doi.org/10.1182/blood-2018-99-112139
Published: 2018
Journal Articles

Health-Related Quality of Life and Patient-Reported Outcomes in Patients Receiving Ofatumumab in Combination with Fludarabine and Cyclophosphamide (FC) Versus FC Alone in the Complement 2 Trial

Tadeusz Robak, MD Professor, Krzysztof Warzocha, MD PhD, K Govind Babu, Yaroslav Kulyaba, Kazimierz Kuliczkowski, Kudrat Abdulkadyrov, MD PhD, Javier Loscertales, Iryna Kryachok, Janusz Kloczko, Grygoriy Rekhtman, Wojciech Homenda, Jerzy Blonski, Astrid McKeown, PhD, Chai-Ni Chang, Stephanie C Manson, Steen Lisby, Ira V. Gupta, MD, Sebastian Grosicki, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5288.
https://doi.org/10.1182/blood.V126.23.5288.5288
Published: 2015
Journal Articles

Switching To Nilotinib In Patients (pts) With Chronic Myeloid Leukemia In Chronic Phase (CML-CP) With Suboptimal Cytogenetic Response (CyR) On Imatinib: First Results Of The LASOR Trial

Jorge E. Cortes, MD, Carmino Antonio De Souza, PhD, Jose Luis Lopez, MD, Manuel Ayala, MD, Eduardo Bullorsky, Xiaojun Huang, Sandip Shah, K. Govind Babu, Tomasz Sacha, MD, Israel Bendit, Zhizhou Liang, Tina Owugah, Prasanna Kumar Nidamarthy, Tomasz Szczudlo, Carmen Piccolo, MD, Philipp D. le Coutre, MD
Journal: Blood
Blood (2013) 122 (21): 95.
https://doi.org/10.1182/blood.V122.21.95.95
Published: 2013